Cell Growth Processes
"Cell Growth Processes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Processes required for CELL ENLARGEMENT and CELL PROLIFERATION.
Descriptor ID |
D048708
|
MeSH Number(s) |
G04.161 G07.345.249.410
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cell Growth Processes".
Below are MeSH descriptors whose meaning is more specific than "Cell Growth Processes".
This graph shows the total number of publications written about "Cell Growth Processes" by people in this website by year, and whether "Cell Growth Processes" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 4 | 4 | 2006 | 0 | 2 | 2 | 2007 | 0 | 2 | 2 | 2008 | 0 | 4 | 4 | 2009 | 0 | 2 | 2 | 2010 | 0 | 4 | 4 | 2011 | 0 | 3 | 3 | 2012 | 0 | 4 | 4 | 2013 | 0 | 4 | 4 | 2014 | 0 | 1 | 1 | 2016 | 0 | 2 | 2 | 2017 | 0 | 2 | 2 | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Growth Processes" by people in Profiles.
-
Chen Y, Li X, Mamouni K, Yang Y, Danaher A, White J, Liu H, Kucuk O, Gera L, Wu D. Novel small-molecule LG1836 inhibits the in vivo growth of castration-resistant prostate cancer. Prostate. 2020 09; 80(12):993-1005.
-
Mart?nez-L?inez JM, Moreno DF, Parisi E, Clotet J, Aldea M. Centromeric signaling proteins boost G1 cyclin degradation and modulate cell size in budding yeast. PLoS Biol. 2018 08; 16(8):e2005388.
-
Tomar MS, Kumar S, Kumar S, Gautam PK, Singh RK, Verma PK, Singh SP, Acharya A. NK Cell Effector Functions Regulation by Modulating nTreg Cell Population During Progressive Growth of Dalton's Lymphoma in Mice. Immunol Invest. 2018 Jan; 47(1):40-56.
-
Paudyal P, Xie Q, Vaddi PK, Henry MD, Chen S. Inhibiting G protein ?? signaling blocks prostate cancer progression and enhances the efficacy of paclitaxel. Oncotarget. 2017 May 30; 8(22):36067-36081.
-
Kessler BE, Sharma V, Zhou Q, Jing X, Pike LA, Kerege AA, Sams SB, Schweppe RE. FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes. Mol Cancer Res. 2016 09; 14(9):869-82.
-
Qin JJ, Wang W, Sarkar S, Voruganti S, Agarwal R, Zhang R. Inulanolide A as a new dual inhibitor of NFAT1-MDM2 pathway for breast cancer therapy. Oncotarget. 2016 May 31; 7(22):32566-78.
-
Roche AM, Richard AL, Rahkola JT, Janoff EN, Weiser JN. Antibody blocks acquisition of bacterial colonization through agglutination. Mucosal Immunol. 2015 Jan; 8(1):176-85.
-
Korets SB, Musa F, Curtin J, Blank SV, Schneider RJ. Dual mTORC1/2 inhibition in a preclinical xenograft tumor model of endometrial cancer. Gynecol Oncol. 2014 Feb; 132(2):468-73.
-
Arcaroli JJ, Quackenbush KS, Purkey A, Powell RW, Pitts TM, Bagby S, Tan AC, Cross B, McPhillips K, Song EK, Tai WM, Winn RA, Bikkavilli K, Vanscoyk M, Eckhardt SG, Messersmith WA. Tumours with elevated levels of the Notch and Wnt pathways exhibit efficacy to PF-03084014, a ?-secretase inhibitor, in a preclinical colorectal explant model. Br J Cancer. 2013 Aug 06; 109(3):667-75.
-
Hiester BG, Galati DF, Salinas PC, Jones KR. Neurotrophin and Wnt signaling cooperatively regulate dendritic spine formation. Mol Cell Neurosci. 2013 Sep; 56:115-27.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|